These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 35263807

  • 1. Seroprevalence and burden of hepatitis C virus infection in WHO South-East Asia Region: A systematic review.
    Goel A, Rewari BB, Sharma M, Konath NM, Aggarwal R.
    J Gastroenterol Hepatol; 2022 Jun; 37(6):964-972. PubMed ID: 35263807
    [Abstract] [Full Text] [Related]

  • 2. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
    Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, Stone J, Cunningham EB, Trickey A, Dumchev K, Lynskey M, Griffiths P, Mattick RP, Hickman M, Larney S.
    Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of hepatitis C virus infection among key populations in China: A systematic review.
    Liu CR, Li X, Chan PL, Zhuang H, Jia JD, Wang X, Lo YR, Walsh N.
    Int J Infect Dis; 2019 Mar; 80():16-27. PubMed ID: 30529371
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019.
    Facente SN, Grinstein R, Bruhn R, Kaidarova Z, Wilson E, Hecht J, Burk K, Grebe E, Morris MD.
    PLoS One; 2022 Mar; 17(5):e0267902. PubMed ID: 35544483
    [Abstract] [Full Text] [Related]

  • 5. Characteristics associated with HIV and hepatitis C seroprevalence among sexual and injecting partners of HIV positive persons who inject drugs in Nairobi and coastal Kenya.
    Sambai BC, Kingston H, Monroe-Wise A, Mbogo L, Juma E, Ludwig-Barron N, Guthrie BL, Bukusi D, Chohan BH, Scott J, Bosire R, Dunbar M, Macharia P, Masyuko S, Sinkele W, Herbeck JT, Farquhar C.
    BMC Infect Dis; 2022 Jan 21; 22(1):73. PubMed ID: 35062890
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
    Falla AM, Hofstraat SHI, Duffell E, Hahné SJM, Tavoschi L, Veldhuijzen IK.
    BMC Infect Dis; 2018 Feb 12; 18(1):79. PubMed ID: 29433454
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and Disease Burden of HCV Coinfection in HIV Cohorts in the Asia Pacific Region: A Systematic Review and Meta-Analysis.
    Martinello M, Amin J, Matthews GV, Dore GJ.
    AIDS Rev; 2016 Feb 12; 18(2):68-80. PubMed ID: 27196354
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis C Virus Seroprevalence in Persons Who Inject Drugs in Korea, 2012-2022: A Multicenter, Retrospective Study.
    Kim J, Choi GH, Jang OJ, Chon Y, Cho SN, Kwon D, Jeong SH.
    J Korean Med Sci; 2023 Dec 11; 38(48):e357. PubMed ID: 38084024
    [Abstract] [Full Text] [Related]

  • 9. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
    Degenhardt L, Webb P, Colledge-Frisby S, Ireland J, Wheeler A, Ottaviano S, Willing A, Kairouz A, Cunningham EB, Hajarizadeh B, Leung J, Tran LT, Price O, Peacock A, Vickerman P, Farrell M, Dore GJ, Hickman M, Grebely J.
    Lancet Glob Health; 2023 May 11; 11(5):e659-e672. PubMed ID: 36996857
    [Abstract] [Full Text] [Related]

  • 10. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    Solomon SS, McFall AM, Lucas GM, Srikrishnan AK, Kumar MS, Anand S, Quinn TC, Celentano DD, Mehta SH.
    PLoS Med; 2017 Nov 11; 14(11):e1002460. PubMed ID: 29182638
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A, Young K, Versfeld A, Spearman CW, Sonderup MW, Prabdial-Sing N, Puren A, Hausler H.
    BMC Infect Dis; 2020 Sep 07; 20(1):655. PubMed ID: 32894072
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.
    Bao Y, Larney S, Peacock A, Colledge S, Grebely J, Hickman M, Degenhardt L, Leung J.
    Int J Drug Policy; 2019 Aug 07; 70():87-93. PubMed ID: 31125802
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis.
    Aghaei AM, Gholami J, Sangchooli A, Rostam-Abadi Y, Olamazadeh S, Ardeshir M, Baheshmat S, Shadloo B, Taj M, Saeed K, Rahimi-Movaghar A.
    Lancet Glob Health; 2023 Aug 07; 11(8):e1225-e1237. PubMed ID: 37474230
    [Abstract] [Full Text] [Related]

  • 14. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.
    Artenie A, Stone J, Fraser H, Stewart D, Arum C, Lim AG, McNaughton AL, Trickey A, Ward Z, Abramovitz D, Alary M, Astemborski J, Bruneau J, Clipman SJ, Coffin CS, Croxford S, DeBeck K, Emanuel E, Hayashi K, Hermez JG, Low-Beer D, Luhmann N, Macphail G, Maher L, Palmateer NE, Patel EU, Sacks-Davis R, Van Den Boom W, van Santen DK, Walker JG, Hickman M, Vickerman P, HIV and HCV Incidence Review Collaborative Group.
    Lancet Gastroenterol Hepatol; 2023 Jun 07; 8(6):533-552. PubMed ID: 36996853
    [Abstract] [Full Text] [Related]

  • 15. Estimating prevalence and modelling correlates of HIV test positivity among female sex workers, men who have sex with men, people who inject drugs, transgender people and prison inmates in Sierra Leone, 2021.
    Dwomoh D, Wurie I, Harding Y, Sedzro KM, Kandeh J, Tagoe H, Addo C, Arhinful DK, Sessay ARC, Kamara JL, Mansaray K, Ampofo WK.
    AIDS Res Ther; 2023 Sep 27; 20(1):70. PubMed ID: 37759241
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Burden of hepatitis C virus infection in India: A systematic review and meta-analysis.
    Goel A, Seguy N, Aggarwal R.
    J Gastroenterol Hepatol; 2019 Feb 27; 34(2):321-329. PubMed ID: 30176181
    [Abstract] [Full Text] [Related]

  • 18. A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?
    Leung J, Peacock A, Colledge S, Grebely J, Cunningham EB, Hickman M, Vickerman P, Stone J, Trickey A, Dumchev K, Lynskey M, Hines L, Griffiths P, Mattick RP, Degenhardt L, Larney S.
    J Infect Dis; 2019 Jun 05; 220(1):78-90. PubMed ID: 30726973
    [Abstract] [Full Text] [Related]

  • 19. Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis.
    Smith DJ, Jordan AE, Frank M, Hagan H.
    BMC Infect Dis; 2016 Sep 05; 16(1):471. PubMed ID: 27595855
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of HIV, HCV and HBV in Central Asia and the Caucasus: A systematic review.
    Davlidova S, Haley-Johnson Z, Nyhan K, Farooq A, Vermund SH, Ali S.
    Int J Infect Dis; 2021 Mar 05; 104():510-525. PubMed ID: 33385583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.